Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
In recent decades, a significant role for altered immunoinflammatory, oxidative and nitrosative stress (IO&NS) pathways in schizophrenia has been recognized (Smith and Maes, 1995; Wood et al., 2009). Importantly, such processes have provided crucial clues to the etiology, course and management of this devastating disorder. This is the focus of this special edition. Epidemiological findings supporting a role for prenatal viral, bacterial and protozoan infections in the etiology of schizophrenia have provided a seminal contribution to the neurodevelopmental hypothesis of schizophrenia (Brown and Derkits, 2010). The early developmental etiology of schizophrenia to a lesser extent has been focused on decreased vitamin D in early development, including via vitamin D modulation of the immune response to infection (McGrath et al., 2003). Interactions between these factors is suggested by the fact that vitaminDhas a documented role in immunemodulation, especially during placental development and in early childhood (Battersby et al., 2012; Liu et al., 2011). The maximal risk period for maternal infection association with offspring schizophrenia is shown to be early pregnancy (Brown et al., 2004; Khandaker et al., 2012). Interestingly many schizophrenia susceptibility genes are regulated by hypoxia, suggesting close interactions among IO&NS genes and obstetric complications leading to enhanced risk of schizophrenia (Nicodemus et al., 2008; Schmidt-Kastner et al., 2006). Other conditions of pregnancy, including hypoxia associated preeclampsia (Kendell et al., 1996), also increase the risk of the offspring being classed as having schizophrenia, emphasizing the profound impact of prenatal events. The evidence for the role of prenatal infection, both epidemiological and experimental, is excellently reviewed byUrsMeyer (2013–this issue) who has published extensively in this area. Many of the developmental effects of infection are driven not only by O&NS and proinflammatory cytokine increases in the placenta and fetus, but also by associated hypoferremia and zinc deficiency (Ganz and Nemeth, 2009; Prasad, 2009). Such changes render the offspring prone to subsequent second hits over the course of post-natal development, contributing to both the emergence and progression of disease manifestations. This is an important area of experimental research given that the elimination of the effects of maternal infection is estimated to decrease the incidence of schizophrenia by as much as 46% (Brown and Derkits, 2010).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prenatal Infection and Schizophrenia: A Review of Epidemiologic and Translational Studies
Brown, A. S., & Derkits, E. J. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09030361 · Cited by 1,269
The Neurodevelopmental Hypothesis of Schizophrenia, Revisited
Fatemi, S. H., & Folsom, T. D. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn187 · Cited by 860 · cited 1×
“Some have suggested that the second hit occurs around adolescence, being associated with excessive synaptic pruning and subsequent decreases in synaptic plasticity (Fatemi and Folsom, 2009).”
BackgroundSelf-citationMeyer, U., Nyffeler, M., Engler, A., Urwyler, A., Schedlowski, M., Knuesel, I., Yee, B. K., & Feldon, J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0099-06.2006 · Cited by 774
Self-citationFillman, S. G., Cloonan, N., Catts, V. S., Miller, L. C., Wong, J., McCrossin, T., Cairns, M., & Weickert, C. S. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.110 · Cited by 609
Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice
Krstic, D., Madhusudan, A., Doehner, J., Vogel, P., Notter, T., Imhof, C., Manalastas, A., Hilfiker, M., Pfister, S., Schwerdel, C., et al. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-151 · Cited by 400
Iron Sequestration and Anemia of Inflammation
Ganz, T., & Nemeth, E. (2009) · Seminars in Hematology · doi:10.1053/j.seminhematol.2009.06.001 · Cited by 361
Beumer, W., Gibney, S. M., Drexhage, R. C., Pont-Lezica, L., Doorduin, J., Klein, H. C., Steiner, J., Connor, T. J., Harkin, A., Versnel, M. A., et al. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0212100 · Cited by 347 · cited 1×
“Another significant commonality between schizophrenia and the mood disorders is the increased level of microglia activation (Beumer et al., 2012; Fillman et al., in press).”
BackgroundNeuroinflammation in schizophrenia especially focused on the role of microglia
Monji, A., Kato, T. A., Mizoguchi, Y., Horikawa, H., Seki, Y., Kasai, M., Yamauchi, Y., Yamada, S., & Kanba, S. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.12.002 · Cited by 314
Self-citationViral infection, inflammation and schizophrenia
Kneeland, R. E., & Fatemi, S. H. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.02.001 · Cited by 152 · cited 1×
“Additionally, effects of various viral strains are not always similar to the effects of poly: I.C. in different experimental protocols (Kneeland and Fatemi, 2013–this issue).”
BackgroundSelf-citationShibakawa, Y. S., Sasaki, Y., Goshima, Y., Echigo, N., Kamiya, Y., Kurahashi, K., Yamada, Y., & Andoh, T. (2005) · British Journal of Anaesthesia · doi:10.1093/bja/aei256 · Cited by 96
Cited by
Neuroinflammation and psychiatric illness
Najjar, S., Pearlman, D. M., Alper, K., Najjar, A., & Devinsky, O. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-43 · Cited by 733
“oxidant elimination, defective antioxidant defenses, or some combination thereof [206-209].”
InfluentialInflammation in schizophrenia: pathogenetic aspects and therapeutic considerations.
Müller, N. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sby024 · Cited by 648
Self-citationNutritional psychiatry: The present state of the evidence
Marx, W., Moseley, G., Berk, M., & Jacka, F. (2017) · Proceedings of the Nutrition Society · doi:10.1017/s0029665117002026 · Cited by 469
Self-citationThe role of inflammation in schizophrenia
Müller, N., Weidinger, E., Leitner, B., & Schwarz, M. J. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00372 · Cited by 465
Self-citationMitochondrial dysfunction in schizophrenia: Pathways, mechanisms and implications
Rajasekaran, A., Venkatasubramanian, G., Berk, M., & Debnath, M. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.11.005 · Cited by 279
Self-citation
Metadata
- Authors
- Anderson, G., Berk, M., Dodd, S., Bechter, K., Altamura, A. C., Dell'Osso, B., Kanba, S., Monji, A., Fatemi, S. H., Buckley, P., Debnath, M., Das, U. N., Meyer, U., Müller, N., Kanchanatawan, B., & Maes, M.
- Venue
- Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2013-04
- Volume
- 42
- Pages
- 1-4
- ISSN
- 0278-5846 (ISSN-L)
- OpenAlex
- W2014780789
- Cited by
- 140
- References
- 11
- FWCI
- 3.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia. https://app.cochat.ai/papers/10.1016/j.pnpbp.2012.10.008
- The paper
- Anderson, G., Berk, M., Dodd, S., Bechter, K., Altamura, A. C., Dell'Osso, B., Kanba, S., Monji, A., Fatemi, S. H., Buckley, P., Debnath, M., Das, U. N., Meyer, U., Müller, N., Kanchanatawan, B., & Maes, M. (2013). Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry. https://doi.org/10.1016/j.pnpbp.2012.10.008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.